In the present study, we evaluated the in vitro and in vivo anti-angiogenic and anti-tumor activities of 2-hydroxy-4-methoxychalcone (HMC). HMC decreased angiogenesis in both chick embryos in the chorioallantoic membrane assay and basic fibroblast growth factor (bFGF)-induced vessel formation in the mouse Matrigel plug assay. This compound also reduced the proliferation of calf pulmonary arterial endothelial cells and was found to possess relatively weak gelatinase/collagenase inhibitory activity in vitro. HMC, when administered subcutaneously at the dose of 30 mg/kg for 20 d to mice implanted with murine Lewis lung carcinoma, caused a significant inhibition of tumor volume by 27.2%. Intraperitoneal (i.p.) treatment at the same dosage for 10 d to ICR mice bearing sarcoma 180 caused a significant suppression in tumor weight by 33.7%. Taken together, out data demonstrate that the anti-angiogenic activities of HMC might be due to anti-proliferative activity under inhibition of the induction of COX-2 enzyme. Furthermore, the results suggest that the potent anti-angiogenic activity of HMC seems to be the possible mechanism of action in these animal models of solid tumors.
Angiogenesis is the process of generating new capillary blood vessels. In the adult, the proliferation rate of endothelial cells is very low compared with that of many other cell types in the body. Angiogenesis occurs under tight regulation in the female reproductive system and during wound healing.
1) Unregulated angiogenesis may result in different pathologies, 2) such as rheumatoid arthritis, 3) diabetic retinopathy, 4) psoriasis, and juvenile hemangiomas. 5) Also, tumor growth and metastasis are angiogenesis-dependent. 6) Chalcones are precursor compounds for flavonoid synthesis in plants. Naturally occurring chalcones exist mostly in hydroxylated forms and many reports have documented their biologically active properties. 7) It has recently been reported that cyclooxygenase-2 (COX-2) induces angiogenesis, which is essential for tumor growth. Increased prostaglandin production and enhanced release of angiogenic growth factor by COX-2 may induce neovascularization. COX inhibitors exhibit dramatic anti-angiogenic activity in a number of tumor model systems. 8) In a previous study, we reported that 2Ј-hydroxy-4Ј-methoxychalcone (HMC), a synthetic chalcone inhibited PGE 2 production in 12-O-tetradecanoylphorbol 13-acetate (TPA)-stimulated rat peritoneal macrophages by inhibiting the induction of COX-2 protein. 9) In view of the involvement of COX-2 in angiogenesis, the purpose of the present study was to determine the anti-angiogenic activities of HMC and to use it as an anti-tumor agent. We investigated the possible effects of HMC on angiogenesis using a chorioallantoic membrane (CAM) assay and an in vivo matrigel assay. Also, we found an effect on the proliferation of calf pulmonary arterial endothelial (CPAE) cells and gelatinase/collagenase, and observed substantial anti-tumor activity against sarcoma 180-induced solid tumors and primary tumors in Lewis lung carcinoma (LLC)-bearing C57BL/6 mice.
MATERIALS AND METHODS

Materials
The first grade solvents were used for extraction, fractionation, and column chromatography. Kiesel gel 60 (70-230 mesh, Art, 7734 Merck) was used as the column packing material. Kiesel 60 F 254 (precoated plate, Art. 5559, Merck) was used for thin layer chromatography (TLC). Iodine vapor and 10% H 2 SO 4 were used for TLC detection.
Heparin and Drabkin's reagent kit were purchased from Sigma Chem. Co. Ltd. (St. Louis, MO, U.S.A.). Trypsin-EDTA, penicillin-streptomycin, fetal bovine serum, DMEM (Dulbecco's Modified Eagle Medium), RPMI 1640 medium, and bFGF (basic fibroblast growth factor) were obtained from GIBCO/BRL (Gaithersburg, MD, U.S.A.). 5-Fluorouracil and all-trans-retinoic acid were purchased from Sigma-Aldrich. Thermanox plastic cell culture coverslips (13 mm diameter) were purchased from Nalge-Nunc International (Naperville, IL, U.S.A.). Intralipose (10%) was supplied by Korea Green Cross Corp. (Seoul, Korea). Matrigel basement membrane matrix was purchased from Collaborative Biomedical Products (Bedford, MA, U.S.A.), while the gelatinase/collagenase assay kits were purchased from Molecular Probes (Eugene, OR, U.S.A.).
HMC HMC was synthesized according to the method described in a previous paper. 10) Chemical structures are shown in Fig. 1 .
Animals All animal studies were carried out in a pathogen-free barrier zone at Seoul National University Hos- pital in accordance with procedures outlined in the Guide for the Care and Use of Laboratory Animals. All animals were acclimated at least for one week, caged in groups of 5 or less, and fed a diet of animal chow and water ad libitum. They were housed at 23Ϯ0.5°C and 10% humidity in a 12 h light-dark cycle.
Anti
Cells LLC cells were purchased from ATCC (American Type Culture Collection, Rockville, MD, U.S.A.). Sarcoma 180 and calf pulmonary arterial endothelial cells were obtained from KCLB (Korea Cell Line Bank, Seoul, Korea).
CAM Assay The CAM assay was carried out according to the procedures described previously. 11, 12) Fertilized chicken eggs were incubated in a constant humidified breeder at 37°C. On the third day of incubation, about 2 ml of egg albumin was aspirated using an 18-gauge hypodermic needle to detach the developing CAM from the shell. One and a half days later, HMC (30 mg/egg)-loaded thermanox coverslips were air-dried and applied to the CAM surface. transRetinoic acid was used as a positive control. Two days later, 1 ml of 10% intralipose was injected into the chorioallantois and observations were performed under dissecting microscope.
CPAE Cell Proliferation Assay CPAE cells in triplicate were plated at a density of 1ϫ10 5 cells/well. After 24 h incubation, nonadherent cells were aspirated and adherent cells were washed twice with RPMI media and then treated with various concentrations of HMC and/or bFGF. Genistein was used as a positive control. The cells were incubated at 37°C for 3 d, the old media were discarded, and then 1 ml of new media and 10 ml of MTT solution were added to each well. After incubation at 37°C for 4 h, the media and MTT solution were discarded and 1 ml of 100% DMSO was added to each well.
13) The O.D. values of each sample-treated cell at 540 nm were compared to those of control cells.
Gelatinase and Collagenase Assay The gelatinase and collagenase assay was performed by a method previously described. 14) Gelatinase and collagenase activities were quantitated using a gelatinase/collagenase assay kit. Each sample was incubated with 100 mg/ml gelatin fluorescein conjugate (DQ gelatin) substrate and 0.2 U/ml Clostridium collagenase for 24 h at room temperature in 96-well plates. Gelatinase activity was measured as the increase in fluorescent units (excitation, 495 nm and emission, 515 nm). The metalloproteinase inhibitor 1,10-phenanthroline was used as a positive control.
Matrigel Plug Assay The matrigel plug assay was performed by a method previously described. 15) Sample, bFGF (100 ng/ml), and heparin (10 units/ml, dissolved in 0.1% BSA/PBS) were mixed with liquid matrigel. A mixture of 0.5 ml matrigel at 4°C containing HMC (50 mg/ml), bFGF (100 ng/ml), and heparin (10 units/ml) was injected subcutaneously into C57BL/6 mice. bFGF with heparin was used as a positive control. After 7 d, the amount of hemoglobin in the matrigel was measured using Drabkin's reagent kit 535.
Measurement of Solid Tumors in LLC in C57BL/6 Mice For the implantations, Lewis lung carcinoma cells were adjusted to 1ϫ10 7 cells/ml. C57BL/6 mice were then injected with 0.1 ml of the suspension into the subcutaneous dorsa in the proximal midline. After the tumor volume became at least 80-95 mm 3 , which occurred within 6 d, the mice were randomized into each group. HMC (30 mg/kg) was injected subcutaneously once daily at a site distant from the tumor. Doxorubicin (15 mg/kg) as a positive control was injected intravenously every two days. During the administration period, tumor volume was measured in two dimensions using calipers. Animals were killed under anesthesia on day 20. Tumors were measured with digital calipers every two days and volume was determined using the formula width 2 ϫlengthϫ0.52.
16)
Measurement of Solid Tumors in Sarcoma 180 in Mice
Statistics Statistical comparisons between groups were performed using the Student's t-test. Significance was accepted at pϽ0.05.
RESULTS
Effect on Chick Embryonic Angiogenesis
To assess the anti-angiogenic activity of HMC, the effect on angiogenesis was estimated using the CAM assay. The results are shown in Table 1 and Fig. 2 . HMC was found to cause a significant suppression of embryonic angiogenesis. HMC showed strong anti-angiogenic activity (by 68.4%) at a dose of 30 mg/pellet. trans-Retinoic acid, a positive reference compound, significantly inhibited (by 77.3%) the angiogenic response at a dose of 1 mg/pellet.
Effect on Calf Pulmonary Artery Endothelial (CPAE) Cell Proliferation
The effect on the proliferation of CPAE cells was assessed, and the results are shown in Table 2 . CPAE cells, when incubated in the presence of HMC, were significantly inhibited in a concentration-dependent manner with a IC 50 value of 12.7 mM. The IC 50 value for genistein as a positive control was 66.9 mM.
Effect on Gelatinase/Collagenase Activity The effect on gelatinase/collagenase activity was investigated using a gelatinase/collagenase assay kit. HMC exhibited relatively weak inhibition about 30% at 1 mM, while 1,10-phenanthro- HMC was applied to the CAM surface of 4.5-d chick embryo. Two days later, 1 ml of 10% fat emulsion was injected into the CAM, and the result was observed under a microscope. Anti-angiogenic responses were scored as positive when the compoundtreated CAM showed an avascular zone similar to trans-retinoic acid-treated CAM, which had few vessels compared to control, and calculated by the percentage of positive eggs. a) trans-Retinoic acid was used as a positive control.
line, a positive control compound, was found to exhibit a strong inhibitory activity in a concentration-dependent manner (Table 3) .
Effect on bFGF-Stimulated Angiogenesis To quantitate the angiogenic response, we measured the hemoglobin content inside the matrigel plugs. Measurement of hemoglobin indicated the degree of formation of functional vasculature inside the matrigel. bFGF and heparin increased hemoglobin to 11.1 g/dl, while hemoglobin in the control was 0.3 g/dl (Fig. 3) . HMC significantly decreased the bFGF-elevated hemoglobin level to 6.8 g/dl (pϽ0.05).
Effect on Tumor Growth in Lewis Lung Carcinoma in C57BL/6 Mice To determine whether HMC could inhibit primary tumor growth or not, HMC was administered to C57BL/6 mice bearing subcutaneous Lewis lung carcinomas. The results are shown in Fig. 4 . Daily subcutaneous injection for 20 d was found to cause a gradual decrease in the growth of primary tumors during the treatment course. At the end of the treatment, tumor growth was found to be inhibited by 27.2% compared to control mice treated with saline alone. Vol. 29, No. 5 Each sample was incubated with 100 mg/ml gelatin fluorescein conjugate (DQ gelatin) substrate and 0.2 U/ml Clostridium collagenase for 24 h at room temperature in 96-well plates. Gelatinase/collagenase activity was measured as the increase in fluorescent units (excitation, 495 nm and emission, 515 nm). Enzyme activity was quantitated based on a standard curve prepared with 0.5-50 ng of bacterial collagenase. a) 1,10-Phenanthroline was used as a positive control. 
. Effect on Angiogenesis in Mouse Model
Matrigel at 4°C mixed with 100 ng/ml bFGF and 10 units/ml of heparin in a vehicle consisting of 0.1% PBS with or without 50 mg/ml of test compound was injected s.c. into C57BL/6 mice. Matrigel alone was used as a negative control and a mixture of 100 ng/ml bFGF and 10 units/ml heparin was used as a positive control. After 7 d, the mice were killed and their skins pulled back to expose the matrigel plug. The amount of Hb inside the matrigel was measured using the Drabkin reagent kit 525. The data are presented as the meanϮS.E.M. of 5 animals. Significantly different from the control group; * pϽ0.05. 
DISCUSSION
In this study, HMC was demonstrated to be a novel angiogenic inhibitor that was sufficiently potent to suppress angiogenesis in vitro and in vivo.
Previously, we reported that HMC inhibited the induction of COX-2 protein. 9) One of the mechanisms of the anticancer activity of COX is the suppression of angiogenesis. Many reports have described the direct relationship between COX and angiogenesis, and the suppression of angiogenesis by COX inhibitors has been demonstrated. 17, 18) COX-2 has been detected not only in most colon, lung, breast, and prostate tumors in humans, but also in the angiogenic vasculature in the tumors. It was also reported that cornea blood vessel formation was suppressed by a selective COX-2 inhibitor but not by a COX-1 inhibitor in a rat model of angiogenesis, suggesting that COX-2 plays a critical role in tumor angiogenesis. 19) In the present study, the anti-angiogenic activity of HMC, a synthetic chalcone, was investigated by a method using CAM and matrigel plug assays. This compound inhibited vascular formation by 68.4% at 30 mg/egg and suppressed abnormal excessive angiogenesis in a bFGF-enhancing matrigel plug assay.
The growth of vascular endothelial cells is one of the important steps during angiogenesis. Indeed, several angiogenesis factors, including acidic and basic fibroblast growth factors and epidermal growth factor, exhibit mitogenic activity toward vascular endothelial cells.
HMC significantly inhibited cell growth dose dependently, with the IC 50 value being 12.7 mM.
The anti-angiogenic mode of HMC, possessing suppression of COX-2 protein, was associated with the inhibitory action on endothelial cell proliferation. 9) Selective COX-2 inhibitors suppress proliferation and induce apoptosis in certain cancer cells. Some of these studies have addressed the association of the anti-proliferative or apoptosis-inducing activities of Non-Steroidal Anti-inflammatory Drugs (NSAIDs) with their suppression of COX-2 enzyme. 20) Based on the above findings, we investigated its anti-tumorigenic activity. HMC showed substantial anti-tumor activity against primary tumors in LLC bearing C57BL/6 mice. At the end of treatment, tumor growth was inhibited by 27.2% compared to control mice treated with saline alone. Also, the effect of HMC on solid tumors induced by sarcoma 180 tumor cells as measured by the tumor weight in mice was examined. Tumor weight in the groups treated with HMC decreased by 33.7% compared with the control.
Therefore, the anti-angiogenic activities of HMC might be due to anti-proliferative activity under inhibition of the induction of COX-2 enzyme. Furthermore, the results suggest that the potent anti-angiogenic activity of HMC may be the mechanism of action in these animal models of solid tumors.
Accordingly, we believe that HMC may be a promising candidate as an angiogenesis inhibitor. 
